ADC Therapeutics ADCT
NYSE ADCT
$0.98 +0.02 (+2.00%)
As of: Aug 21, 2026 · 9:47 AM EDT

ADC Therapeutics (ADCT) EPS (Diluted) (2022 - 2026)

ADC Therapeutics (ADCT) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.76 Bn 130.91 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 86.15 Bn 78.15 Bn 3.93 Bn 12.23
3 Argenx Se 64.45 Bn 59.27 Bn 1.37 Bn 7.33
4 Moderna 57.08 Bn 51.94 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.08 Bn 36.99 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.90 Bn 27.59 Bn 992.69 Mn 1.19
7 BioNTech SE 27.76 Bn 9.37 Bn 668.28 Mn -0.72
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.00 Bn 26.17 Bn - 0.15
10 ADC Therapeutics 150.47 Mn -68.63 Mn 17.14 Mn -0.11

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.11
Mar 31, 2026 -0.21
Sep 30, 2025 -0.30
Jun 30, 2025 -0.50
Mar 31, 2025 -0.36
Sep 30, 2024 -0.42
Jun 30, 2024 -0.38
Mar 31, 2024 -0.56
Sep 30, 2023 -0.55
Jun 30, 2023 -0.59
Mar 31, 2023 -0.74
Dec 31, 2022 -0.23